Active	Status	Sponsor type	Region	Phase	Filter
1 Active 1 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wechalekar, Ashutosh
EMN27, NCT04617925 / 2020-004001-32: A Study of Belantamab Mafodotin in Patients With Relapsed or Refractory AL Amyloidosis	Active, not recruiting	2	35	Europe	Belantamab mafodotin	Stichting European Myeloma Network, GlaxoSmithKline	AL Amyloidosis	07/25	07/25